MOSCOW, October 6 /PRNewswire/ -- At the close of the 20th century, the lack of donor blood and the safety of blood medication became one of the most critical problems in the area of health protection on a global scale.

CAMBRIDGE, Mass., May 18 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that the Food and Drug Administration has advised the U.S.

CAMBRIDGE, Mass., March 31 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that it has received several notices from The Nasdaq Stock Market.

CAMBRIDGE, Mass., March 23 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that the U.S.

Earnings for year ended October 31, 2008, contained in Annual Report filed on February 13, 2009, with Going Concern Modification CAMBRIDGE, Mass., Feb.